World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
20462
World Ranking
18810
National Ranking
9379

Richard A. Nash publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard A. Nash sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 260 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard A. Nash D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard A. Nash sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 76 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Richard A. Nash is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily focuses on Medicine, with notable contributions to subfields including Pathology and Forensic Medicine, Neurology, Pulmonary and Respiratory Medicine, Immunology, and Epidemiology.

The scientist has published extensively on topics related to Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Mast Cells and Histamine, Inflammatory Myopathies and Dermatomyositis, Autoimmune Neurological Disorders and Treatments, Dermatologic Treatments and Research, and CNS Lymphoma Diagnosis and Treatment.

Frequent publication venues for their work include:

  • Annals of the Rheumatic Diseases
  • Arthritis & Rheumatology
  • Trends in Ecology & Evolution
  • Annals of Clinical and Translational Neurology
  • Lara D. Veeken

Several recent papers by the scientist include:

  • Horizon Scan of the Belt and Road Initiative, 2020, Trends in Ecology & Evolution
  • Machine learning predicts stem cell transplant response in severe scleroderma, 2020, Annals of the Rheumatic Diseases
  • Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation, 2023, Annals of the Rheumatic Diseases
  • Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis, 2020, Arthritis & Rheumatology
  • Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis, 2022, Annals of the Rheumatic Diseases

The scientist has collaborated frequently with coauthors including:

  • Peter A. McSweeney
  • Daniel E. Furst
  • Maureen D. Mayes
  • Keith M. Sullivan
  • Ashley Pinckney

Best Publications

  • Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

    Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.

    Rainer Storb;Cong Yu;John L. Wagner;H. Joachim Deeg

  • Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

    Richard A. Nash;Joseph H. Antin;Chatchada Karanes;Joseph W. Fay

  • Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

    Mary E D Flowers;Yoshihiro Inamoto;Paul A. Carpenter;Stephanie J. Lee

  • Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

    Voravit Ratanatharathorn;Richard A. Nash;Donna Przepiorka;Steven M. Devine

  • Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

    K. M. Sullivan;E. A. Goldmuntz;L. Keyes-Elstein;P. A. McSweeney

  • Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.

    R A Nash;M S Pepe;R Storb;G Longton

  • Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

    J.T. Slattery;R.A. Clift;C.D. Buckner;J. Radich

  • Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells.

    Vishwanath Bhattacharya;Peter A. McSweeney;Qun Shi;Benedetto Bruno

  • Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

    Sibel Koc;Wendy Leisenring;Mary E. D. Flowers;Claudio Anasetti

  • Duration of immunosuppressive treatment for chronic graft-versus-host disease.

    Betty L. Stewart;Barry Storer;Jan Storek;H. Joachim Deeg

  • High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.

    Richard A. Nash;Richard A. Nash;Peter A. McSweeney;Leslie J Crofford;Muneer Abidi

  • High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

    Richard A. Nash;James D. Bowen;Peter A. McSweeney;Steven Z. Pavletic

  • T cell repertoire following autologous stem cell transplantation for multiple sclerosis.

    Paolo A. Muraro;Harlan Robins;Sachin Malhotra;Michael Howell

  • Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease

    A I Benito;T Furlong;P J Martin;C Anasetti

  • Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.

    Paolo A. Muraro;Marcelo Pasquini;Harold L. Atkins;James D. Bowen

  • Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor

    H. Openshaw;O. Stuve;J.P. Antel;R. Nash

  • Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?

    Jo N. Fleming;Richard A. Nash;D. O. McLeod;David F. Fiorentino

  • High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.

    Peter A. McSweeney;Richard A. Nash;Keith M. Sullivan;Jan Storek

  • Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.

    Rainer Storb;Cong Yu;Todd Barnett;John L. Wagner

Frequent Co-Authors

Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
Keith M. Sullivan
Keith M. Sullivan Duke University
Claudio Anasetti
Claudio Anasetti Fred Hutchinson Cancer Research Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
H. Joachim Deeg
H. Joachim Deeg Fred Hutchinson Cancer Research Center
Hans Peter Kiem
Hans Peter Kiem Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
Ted Gooley
Ted Gooley Fred Hutchinson Cancer Research Center
Mary E.D. Flowers
Mary E.D. Flowers Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying medicine in the USA, exploring alternative or supplementary online degrees can help diversify your career options. For those seeking a swift entry into healthcare, lpn program options provide a fast-track route to becoming a licensed practical nurse, with many flexible online choices available.

Specializing in mental health is another in-demand path. Accredited psych nurse practitioner programs can be completed online, allowing registered nurses to advance with focused training in psychiatric and mental health care.

For those interested in healthcare management or administration, pursuing the cheapest online health science degree is a budget-friendly way to start. Meanwhile, if you are looking to move into leadership roles, consider the cost of mha degree before enrolling in an online master’s program. These diverse pathways offer greater flexibility and affordability while keeping you at the forefront of the evolving healthcare landscape.

Best Scientists Citing Richard A. Nash

Trending Scientists

Recently Published Articles